-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

Targeting of Cytopenias in Low-Risk MDS

Program: Marquee Sessions
Session: ASH-EHA Joint Symposium
Sunday, December 8, 2024, 12:30 PM-1:30 PM

Matteo Giovanni Della Porta, MD

IRCCS Humanitas Research Hospital, Rozzano, Milan, Italy

Disclosures: Della Porta: Bristol Myers Squibb: Consultancy.

See more of: ASH-EHA Joint Symposium
See more of: Marquee Sessions
Previous Presentation | Next Presentation >>